cupure logo
trumpstariffstradetrumptariffglobalpaymarket2025prices

Trump’s 15% tariff on medicines will harm patients, say EU drugmakers

Trade group says levy will reduce access, disrupt supply chains and cut R&DWegovy maker Novo Nordisk’s shares plunge on sales forecastThe European pharmaceutical industry has condemned the US move to put 15% tariffs on medicines imported from the EU, calling the taxes a “blunt instrument” that would harm patients on both sides of the Atlantic.They were responding to a White House text of the deal that inferred the 15% baseline rate on imports from the EU would also apply to drugs if the agreement is implemented on the US side on Friday as expected. Continue reading...

Comments

Similar News

Business News